Meeting NewsVideo

VIDEO: Pearls on using Oxervate for epithelial defects

CHICAGO – William B. Trattler, MD, discusses the benefits of Dompé’s nerve growth factor Oxervate (cenegermin) for treating non-healing epithelial defects at the American Academy of Ophthalmology meeting.

CHICAGO – William B. Trattler, MD, discusses the benefits of Dompé’s nerve growth factor Oxervate (cenegermin) for treating non-healing epithelial defects at the American Academy of Ophthalmology meeting.

    See more from American Academy of Ophthalmology Meeting